About Aristrex
Company Overview
Aristrex is a company registered in the United Kingdom, incorporated on 8 April 2019. According to our records, the firm operates under the official domain aristrex.com and maintains a presence on Facebook and Twitter/X.
Despite its registration in the UK, Aristrex does not hold any recognised regulatory licences from the Financial Conduct Authority (FCA) or any other financial regulator. The absence of regulatory oversight is a significant point for traders to consider.
Regulatory Status
Our review found no evidence that Aristrex is authorised or regulated by any financial supervisory authority. The FXCanary database lists the broker's regulatory status as 'NONE', and no licence numbers or regulatory references are available.
Unregulated brokers operate without the safeguards that regulated entities must provide, such as client fund segregation, negative balance protection, or access to dispute resolution schemes. This lack of oversight inherently increases the risk for any potential client.
Online Presence and Domain Status
Web research indicates that the official domain aristrex.com is currently listed for sale on a third-party domain marketplace, with an asking price of $3,595. This raises serious questions about whether the broker is actively operating or has ceased operations.
A domain offered for sale suggests the entity may not be currently providing services. Combined with the lack of regulatory licences, this creates a highly uncertain situation for any trader considering engagement with this firm.
Social Media and Activity
Aristrex maintains profiles on Facebook and Twitter/X, though the content and recency of activity on these channels could not be verified in depth during our assessment.
Social media can be used to project legitimacy, but without a functioning website or regulatory backing, these accounts alone do not indicate an active, trustworthy brokerage service.
Risk Assessment
Based on the known facts, Aristrex presents a guarded risk profile with an FXCanary Scam Risk Score of 45 out of 100 — indicating a high level of caution is warranted.
The combination of no regulatory licences, a domain listed for sale, and the absence of verifiable trading information strongly suggests that this entity does not operate as a standard retail forex broker. Traders should treat this as a high-risk situation and perform exhaustive due diligence before any commitment.
Overview compiled by FXCanary from regulatory records and public data. full Aristrex review